Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -561,899 | -391,839 | -232,457 | -687,550 | -503,001 |
| Depreciation Amortization | 46,921 | 29,960 | 15,788 | 48,365 | 30,734 |
| Income taxes - deferred | 0 | 0 | N/A | -285,053 | -130,164 |
| Accounts receivable | -7,315 | 2,518 | 25,237 | 53,363 | 20,737 |
| Accounts payable and accrued liabilities | -5,544 | 7,671 | 978 | -49,234 | -46,005 |
| Other Working Capital | -12,496 | -30,849 | -5,500 | -14,147 | -22,998 |
| Other Operating Activity | 149,004 | 78,857 | 20,192 | 873,590 | 570,272 |
| Operating Cash Flow | $-391,329 | $-303,682 | $-175,762 | $-60,666 | $-80,425 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36,525 | -27,227 | -15,526 | -51,393 | -36,922 |
| Purchase Of Investment | -1,066,864 | -704,505 | -381,425 | -2,410,720 | -1,848,921 |
| Sale Of Investment | 1,203,400 | 801,206 | 376,544 | 2,348,295 | 1,842,361 |
| Other Investing Activity | 9 | 1 | 0 | 1,257 | 50,731 |
| Investing Cash Flow | $100,020 | $69,475 | $-20,407 | $-112,561 | $7,249 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 294,383 | 0 | 0 | N/A | N/A |
| Debt Repayment | -9,165 | -3,834 | 5,428 | -16,215 | -14,759 |
| Common Stock Issued | 201,274 | 117,947 | 60,134 | 265,878 | 242,360 |
| Other Financing Activity | -45,438 | -30,292 | -15,146 | -1,252 | -63,242 |
| Financing Cash Flow | $441,054 | $83,821 | $50,416 | $248,411 | $164,359 |
| Exchange Rate Effect | -481 | 1,645 | 499 | 4,708 | 2,591 |
| Beginning Cash Position | 569,299 | 569,299 | 569,299 | 489,407 | 489,407 |
| End Cash Position | 718,563 | 420,558 | 424,045 | 569,299 | 583,181 |
| Net Cash Flow | $149,264 | $-148,741 | $-145,254 | $79,892 | $93,774 |
| Free Cash Flow | |||||
| Operating Cash Flow | -391,329 | -303,682 | -175,762 | -60,666 | -80,425 |
| Capital Expenditure | -36,525 | -27,227 | -15,526 | -51,393 | -36,922 |
| Free Cash Flow | -427,854 | -330,909 | -191,288 | -112,059 | -117,347 |